The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
|Articles|August 19, 2020
Elements of sexual health in gynecologic cancers
Author(s)Contemporary OB/GYN Staff
In a recent podcast episode from OncLive, Don S. Dizon, MD, FACP, FASCO, discusses the primary physical and residual psychological effects of gynecologic cancers on women’s sexual health.
Advertisement
Dizon also covers the challenges of speaking about these topics in the clinic, and how oncologists can help patients manage these difficulties.
Advertisement
Related to this article
Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Jessica Shepherd, MD, MBA, FACOG, joins Missed & Dismissed to discuss why perimenopause is overlooked and how disparities shape who gets care.
Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Missed & Dismissed: From perimenopause to menopause, the transition medicine keeps missing
2
Multi-society framework ties cardiovascular risk to female life stages
3
Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause
4
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
5